Clinical trial

Effects of Respiratory-Gated Transcutaneous Vagal Nerve Stimulation in Major Depression (Phase 1)

NCT04607226

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-11-02

PhaseNA

Study timeline

Study start (actual)2020-11-02Date precision: day

Registry last updated2023-08-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Major Depressive Disorderunresolved

Interventions

Active transcutaneous vagus nerve stimulationOTHER

Sham transcutaneous vagus nerve stimulationOTHER

Sponsors & collaborators

Massachusetts General Hospitallead sponsor

Brain & Behavior Research Foundationcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04607226 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.